Cost-effectiveness analysis of the Lyme disease vaccine.

@article{Hsia2002CosteffectivenessAO,
  title={Cost-effectiveness analysis of the Lyme disease vaccine.},
  author={Elizabeth C. Hsia and James B. Chung and Jerome Sanford Schwartz and Daniel A Albert},
  journal={Arthritis and rheumatism},
  year={2002},
  volume={46 6},
  pages={
          1651-60
        }
}
OBJECTIVE A vaccine for Lyme disease was approved in 1998 for use in the US. Given the high cost of the vaccine, the low risk of Lyme disease in many areas, and the largely curable nature of the disease, the cost-effectiveness of the vaccine in various risk groups is uncertain. This study was undertaken to examine the cost-effectiveness of the Lyme disease vaccine and the factors that influence its cost-effectiveness. METHODS We constructed a Markov decision-analysis model to evaluate the… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-3 of 3 references

The cost - effectiveness of vaccination against Lyme disease

LH Sigal
Archives of Internal Medicine • 2001

The cost effectiveness of vaccinating against Lyme disease

NA Shadick, MH Liang, CB Phillips
Emerging Infectious Diseases • 1999

Cost - effectiveness analysis of the Lyme disease vaccine

MI Meltzer, DT Dennis, KA Orloski
-1